Oral Multiple-dose Study in Patients With Major Depressive Disorder
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
A study was to evaluate the safety and plasma concentration changes of quetiapine after
repeated administration of FK949E (extended-release formulation of quetiapine) in patients
with major depressive disorder (MDD).